Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Temps Différé NSE India S.E. Autres places de cotation 09:51:35 24/04/2024			Varia. 5j.	Varia. 1 janv.
1 398 ^INR	+3,78 %		+3,82 %	+12,23 %

18/04	Le laboratoire indien Biocon développe sa propre version du Wegovy, l'essai clinique devrait avoir lieu l'année prochaine	RE
10/04	Les actions indiennes terminent en hausse mercredi, soutenues principalement par les stocks de métaux	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

India's Biocon developing its own version of Wegovy, clinical trial likely next year	18/04
Cipla's Consumer Healthcare Arm to Acquire Ivia's Cosmetics, Personal-Care Marketing Business	16/04
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks	10/04
Cipla Receives US FDA Observations Following Patalganga Facility Inspection	05/04
Cipla Gets Regulatory Nod to Merge US-Based Subsidiaries	27/03
Cipla to Distribute Sanofi's CNS Product Line in India	27/03
Cipla Limited Appoints Rajeev Kumar Sinha as Senior Management Personnel and Global Chief Manufacturing Officer, Effective April 1, 2024	26/03
Cipla : Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India	26/03
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership	26/03
Losses Led by IT Drag Indian Equities on Tuesday	19/03
Cipla Limited Appoints Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain, Effective from 1 April 2024	15/03
Indian Equities Close with Marginal Gains on Tuesday as IT Stocks See Drop	12/03
Cipla Arm Completes Sale of Entire Stake in Wellthy	07/03
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	28/02
India pharma companies develop versions of Wegovy to get in on weight-loss windfall	22/02
Indian Equities Close Higher Midweek, Led by Banking, IT Stocks	14/02
Indian drugmaker Lupin beats quarterly profit estimates on strong demand	07/02
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	06/02
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	05/02
Cipla Eyes Acquisitions and Inorganic Partnerships in the US, European markets	04/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Autres langues

Filtres